Ms Edith W Johnson, LMFT | |
1033 E Springfield Dr, Bellefonte, PA 16823-8284 | |
(607) 342-5455 | |
(607) 257-0740 |
Full Name | Ms Edith W Johnson |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 1033 E Springfield Dr, Bellefonte, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043393887 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 000036 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Edith W Johnson, LMFT 1033 E Springfield Dr, Bellefonte, PA 16823-8284 Ph: (607) 342-5455 | Ms Edith W Johnson, LMFT 1033 E Springfield Dr, Bellefonte, PA 16823-8284 Ph: (607) 342-5455 |
News Archive
The City of New Orleans Department of Homeland Security and the City of New Orleans Fire Department have selected Upp Technology, Inc. to help improve the efficiency of their day-to-day operations. New Orleans chose Upp's irms|EM (Emergency Management) solution, deployed on the irms|Go-Kit for a mobile inventory management system allowing the city to track inventory through the use of bar-coding at their warehouses and storerooms. Furthermore, the same Go-Kits can then be redeployed to the field in times of emergency to receive and distribute cots, water, food, and other critical supplies needed in Emergency Response.
Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.
Based on preliminary results, the study authors found that elderly people with high lifetime exposure to secondhand smoke were approximately 30 percent more likely to develop dementia than those with no lifetime secondhand smoke exposure.April 28, May 5, 2007.
In a new Phase III study, BRINAVESSTM (vernakalant) intravenous, an investigational compound being developed in the European Union by Merck (known as MSD outside the USA and Canada) and Cardiome Pharma Corp. to treat atrial fibrillation, showed that BRINAVESS was superior to amiodarone injection, in converting patients' heart rate from atrial fibrillation (AF) to sinus rhythm (SR) within 90 minutes of the start of administration.
New research documenting changes in the incidence and outcomes of end-stage renal disease in the U.S. between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans.
› Verified 6 days ago
Peter Rainey, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 179 Chicory Ave, Bellefonte, PA 16823 Phone: 801-920-9054 | |
Shane Landherr, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 221 W High St, Suite 1000, Bellefonte, PA 16823 Phone: 814-531-5659 |